Share Price and Basic Stock Data
Last Updated: March 9, 2025, 8:05 pm
PEG Ratio | 43.49 |
---|
Competitors of Dabur India Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Honasa Consumer Ltd | 7,050 Cr. | 215 | 547/197 | 103 | 35.5 | 0.00 % | 17.1 % | % | 10.0 |
Ambica Agarbathies Aroma & Industries Ltd | 48.7 Cr. | 28.3 | 37.0/23.2 | 18.4 | 60.6 | 0.00 % | 5.07 % | 3.65 % | 10.0 |
Ador Multi Products Ltd | 12.4 Cr. | 26.5 | 45.9/23.4 | 23.2 | 0.00 % | 33.6 % | 26.7 % | 10.0 | |
Kaya Ltd | 311 Cr. | 237 | 702/218 | 106 | 0.00 % | 80.4 % | % | 10.0 | |
Jyothy Labs Ltd | 12,111 Cr. | 330 | 596/310 | 32.5 | 51.4 | 1.06 % | 27.0 % | 21.2 % | 1.00 |
Industry Average | 67,561.71 Cr | 1,901.04 | 46.82 | 109.30 | 0.81% | 36.43% | 29.37% | 4.94 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 2,942 | 2,518 | 2,822 | 2,986 | 3,043 | 2,678 | 3,130 | 3,204 | 3,255 | 2,815 | 3,349 | 3,029 | 3,355 |
Expenses | 2,314 | 2,065 | 2,279 | 2,386 | 2,434 | 2,268 | 2,526 | 2,543 | 2,588 | 2,348 | 2,694 | 2,476 | 2,673 |
Operating Profit | 627 | 452 | 543 | 600 | 609 | 410 | 605 | 661 | 667 | 466 | 655 | 553 | 682 |
OPM % | 21% | 18% | 19% | 20% | 20% | 15% | 19% | 21% | 20% | 17% | 20% | 18% | 20% |
Other Income | 97 | 14 | 101 | 123 | 101 | 121 | 110 | 117 | 127 | 129 | 129 | 152 | 129 |
Interest | 11 | 12 | 12 | 15 | 19 | 32 | 24 | 28 | 36 | 35 | 33 | 47 | 44 |
Depreciation | 63 | 65 | 68 | 70 | 71 | 102 | 97 | 98 | 97 | 107 | 109 | 111 | 109 |
Profit before tax | 650 | 390 | 564 | 638 | 620 | 396 | 593 | 651 | 661 | 453 | 642 | 546 | 658 |
Tax % | 22% | 24% | 22% | 23% | 23% | 26% | 23% | 22% | 23% | 25% | 23% | 24% | 22% |
Net Profit | 504 | 294 | 441 | 491 | 477 | 293 | 457 | 507 | 506 | 341 | 494 | 418 | 516 |
EPS in Rs | 2.85 | 1.66 | 2.49 | 2.77 | 2.69 | 1.70 | 2.62 | 2.91 | 2.90 | 1.97 | 2.82 | 2.40 | 2.95 |
Last Updated: February 28, 2025, 8:14 pm
Below is a detailed analysis of the quarterly data for Dabur India Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹3,355.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,029.00 Cr. (Sep 2024) to ₹3,355.00 Cr., marking an increase of ₹326.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹2,673.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,476.00 Cr. (Sep 2024) to ₹2,673.00 Cr., marking an increase of ₹197.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹682.00 Cr.. The value appears strong and on an upward trend. It has increased from 553.00 Cr. (Sep 2024) to ₹682.00 Cr., marking an increase of ₹129.00 Cr..
- For OPM %, as of Dec 2024, the value is 20.00%. The value appears strong and on an upward trend. It has increased from 18.00% (Sep 2024) to 20.00%, marking an increase of 2.00%.
- For Other Income, as of Dec 2024, the value is ₹129.00 Cr.. The value appears to be declining and may need further review. It has decreased from 152.00 Cr. (Sep 2024) to ₹129.00 Cr., marking a decrease of 23.00 Cr..
- For Interest, as of Dec 2024, the value is ₹44.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 47.00 Cr. (Sep 2024) to ₹44.00 Cr., marking a decrease of 3.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹109.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 111.00 Cr. (Sep 2024) to ₹109.00 Cr., marking a decrease of 2.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹658.00 Cr.. The value appears strong and on an upward trend. It has increased from 546.00 Cr. (Sep 2024) to ₹658.00 Cr., marking an increase of ₹112.00 Cr..
- For Tax %, as of Dec 2024, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 24.00% (Sep 2024) to 22.00%, marking a decrease of 2.00%.
- For Net Profit, as of Dec 2024, the value is ₹516.00 Cr.. The value appears strong and on an upward trend. It has increased from 418.00 Cr. (Sep 2024) to ₹516.00 Cr., marking an increase of ₹98.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is 2.95. The value appears strong and on an upward trend. It has increased from ₹2.40 (Sep 2024) to 2.95, marking an increase of ₹0.55.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 4:30 pm
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 6,140 | 7,058 | 7,795 | 7,780 | 7,614 | 7,722 | 8,515 | 8,685 | 9,562 | 10,889 | 11,530 | 12,404 | 12,548 |
Expenses | 5,148 | 5,897 | 6,475 | 6,261 | 6,102 | 6,104 | 6,775 | 6,892 | 7,560 | 8,637 | 9,367 | 10,004 | 10,192 |
Operating Profit | 992 | 1,162 | 1,320 | 1,518 | 1,512 | 1,617 | 1,740 | 1,792 | 2,002 | 2,252 | 2,162 | 2,400 | 2,356 |
OPM % | 16% | 16% | 17% | 20% | 20% | 21% | 20% | 21% | 21% | 21% | 19% | 19% | 19% |
Other Income | 100 | 126 | 154 | 217 | 296 | 291 | 222 | 205 | 325 | 308 | 445 | 482 | 539 |
Interest | 59 | 54 | 40 | 48 | 54 | 53 | 60 | 50 | 31 | 39 | 78 | 124 | 159 |
Depreciation | 85 | 97 | 115 | 133 | 143 | 162 | 177 | 220 | 240 | 253 | 311 | 399 | 436 |
Profit before tax | 948 | 1,136 | 1,319 | 1,554 | 1,611 | 1,693 | 1,725 | 1,728 | 2,056 | 2,269 | 2,219 | 2,359 | 2,299 |
Tax % | 19% | 19% | 19% | 19% | 21% | 20% | 16% | 16% | 18% | 23% | 23% | 23% | |
Net Profit | 766 | 916 | 1,068 | 1,254 | 1,280 | 1,358 | 1,446 | 1,448 | 1,695 | 1,742 | 1,701 | 1,811 | 1,769 |
EPS in Rs | 4.38 | 5.24 | 6.07 | 7.11 | 7.25 | 7.69 | 8.17 | 8.18 | 9.58 | 9.84 | 9.64 | 10.40 | 10.14 |
Dividend Payout % | 34% | 33% | 33% | 32% | 31% | 81% | 34% | 37% | 50% | 53% | 54% | 53% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 19.58% | 16.59% | 17.42% | 2.07% | 6.09% | 6.48% | 0.14% | 17.06% | 2.77% | -2.35% | 6.47% |
Change in YoY Net Profit Growth (%) | 0.00% | -2.99% | 0.82% | -15.34% | 4.02% | 0.39% | -6.34% | 16.92% | -14.29% | -5.13% | 8.82% |
Dabur India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: December 14, 2024, 3:46 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 174 | 174 | 176 | 176 | 176 | 176 | 177 | 177 | 177 | 177 | 177 | 177 | 177 |
Reserves | 1,921 | 2,482 | 3,178 | 3,995 | 4,671 | 5,530 | 5,455 | 6,429 | 7,487 | 8,205 | 8,796 | 9,689 | 10,185 |
Borrowings | 1,151 | 708 | 734 | 805 | 975 | 938 | 699 | 522 | 509 | 1,030 | 1,174 | 1,365 | 1,752 |
Other Liabilities | 1,462 | 1,948 | 2,019 | 1,956 | 1,910 | 2,058 | 2,106 | 2,209 | 2,661 | 2,872 | 3,505 | 3,885 | 4,259 |
Total Liabilities | 4,709 | 5,312 | 6,106 | 6,932 | 7,732 | 8,702 | 8,437 | 9,337 | 10,833 | 12,284 | 13,652 | 15,116 | 16,373 |
Fixed Assets | 1,582 | 1,767 | 1,877 | 1,667 | 1,958 | 2,028 | 1,969 | 2,253 | 2,243 | 2,308 | 3,579 | 3,815 | 3,874 |
CWIP | 93 | 22 | 50 | 45 | 42 | 42 | 64 | 147 | 147 | 168 | 175 | 232 | 190 |
Investments | 929 | 1,076 | 1,813 | 2,691 | 3,240 | 3,805 | 3,359 | 2,800 | 4,160 | 6,220 | 6,265 | 6,933 | 7,599 |
Other Assets | 2,105 | 2,447 | 2,365 | 2,529 | 2,492 | 2,827 | 3,045 | 4,137 | 4,283 | 3,589 | 3,633 | 4,136 | 4,710 |
Total Assets | 4,709 | 5,312 | 6,106 | 6,932 | 7,732 | 8,702 | 8,437 | 9,337 | 10,833 | 12,284 | 13,652 | 15,116 | 16,373 |
Below is a detailed analysis of the balance sheet data for Dabur India Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹177.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹177.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹10,185.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹9,689.00 Cr. (Mar 2024) to ₹10,185.00 Cr., marking an increase of 496.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹1,752.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹1,365.00 Cr. (Mar 2024) to ₹1,752.00 Cr., marking an increase of 387.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹4,259.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹3,885.00 Cr. (Mar 2024) to ₹4,259.00 Cr., marking an increase of 374.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹16,373.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹15,116.00 Cr. (Mar 2024) to ₹16,373.00 Cr., marking an increase of 1,257.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹3,874.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹3,815.00 Cr. (Mar 2024) to ₹3,874.00 Cr., marking an increase of 59.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹190.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹232.00 Cr. (Mar 2024) to ₹190.00 Cr., marking a decrease of 42.00 Cr..
- For Investments, as of Sep 2024, the value is ₹7,599.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹6,933.00 Cr. (Mar 2024) to ₹7,599.00 Cr., marking an increase of 666.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹4,710.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹4,136.00 Cr. (Mar 2024) to ₹4,710.00 Cr., marking an increase of 574.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹16,373.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹15,116.00 Cr. (Mar 2024) to ₹16,373.00 Cr., marking an increase of 1,257.00 Cr..
Notably, the Reserves (₹10,185.00 Cr.) exceed the Borrowings (1,752.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 991.00 | -707.00 | -733.00 | -804.00 | -974.00 | -937.00 | -698.00 | -521.00 | -507.00 | 1.00 | 1.00 | 1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 29 | 35 | 33 | 38 | 31 | 33 | 36 | 34 | 21 | 22 | 27 | 26 |
Inventory Days | 144 | 150 | 136 | 150 | 153 | 169 | 154 | 164 | 178 | 169 | 158 | 149 |
Days Payable | 122 | 169 | 153 | 182 | 181 | 190 | 172 | 176 | 197 | 178 | 171 | 186 |
Cash Conversion Cycle | 51 | 16 | 16 | 6 | 3 | 13 | 17 | 22 | 3 | 12 | 14 | -10 |
Working Capital Days | 12 | 2 | 7 | 21 | 14 | 21 | 16 | 22 | 5 | 7 | 10 | 2 |
ROCE % | 33% | 35% | 36% | 35% | 31% | 28% | 28% | 28% | 27% | 27% | 23% | 22% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
Mirae Asset Large & Midcap Fund | 8,772,595 | 1.42 | 473.37 | 7,345,248 | 2025-03-10 | 19.43% |
Mirae Asset Large Cap Fund | 7,345,248 | 1.05 | 396.35 | 7,345,248 | 2025-03-10 | 0% |
Mirae Asset ELSS Tax Saver Fund | 5,726,600 | 1.47 | 309.01 | 7,345,248 | 2025-03-10 | -22.04% |
HDFC Top 100 Fund - Regular Plan | 5,414,109 | 0.94 | 292.15 | 7,345,248 | 2025-03-10 | -26.29% |
Kotak Equity Arbitrage Fund - Regular Plan | 4,837,500 | 0.73 | 261.03 | 7,345,248 | 2025-03-10 | -34.14% |
ICICI Prudential Value Discovery Fund | 4,558,165 | 0.62 | 245.96 | 7,345,248 | 2025-03-10 | -37.94% |
Aditya Birla Sun Life Frontline Equity Fund | 4,395,952 | 0.91 | 237.21 | 7,345,248 | 2025-03-10 | -40.15% |
ICICI Prudential Focused Equity Fund | 4,106,614 | 3.25 | 221.59 | 7,345,248 | 2025-03-10 | -44.09% |
UTI Flexi Cap Fund | 3,546,760 | 0.76 | 191.38 | 7,345,248 | 2025-03-10 | -51.71% |
SBI Arbitrage Opportunities Fund | 3,412,500 | 0.69 | 184.14 | 7,345,248 | 2025-03-10 | -53.54% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Basic EPS (Rs.) | 10.40 | 9.64 | 9.84 | 9.58 | 8.18 |
Diluted EPS (Rs.) | 10.38 | 9.61 | 9.81 | 9.55 | 8.15 |
Cash EPS (Rs.) | 12.48 | 11.37 | 11.30 | 10.95 | 9.44 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 58.14 | 53.29 | 47.64 | 43.57 | 37.59 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 58.14 | 53.29 | 47.64 | 43.57 | 37.59 |
Revenue From Operations / Share (Rs.) | 70.00 | 65.07 | 61.59 | 54.01 | 49.15 |
PBDIT / Share (Rs.) | 16.27 | 14.73 | 14.97 | 13.17 | 11.87 |
PBIT / Share (Rs.) | 14.01 | 12.97 | 13.54 | 11.81 | 10.62 |
PBT / Share (Rs.) | 13.31 | 12.53 | 12.84 | 11.64 | 9.78 |
Net Profit / Share (Rs.) | 10.22 | 9.61 | 9.87 | 9.60 | 8.19 |
NP After MI And SOA / Share (Rs.) | 10.40 | 9.64 | 9.84 | 9.58 | 8.18 |
PBDIT Margin (%) | 23.23 | 22.63 | 24.30 | 24.38 | 24.15 |
PBIT Margin (%) | 20.02 | 19.93 | 21.98 | 21.86 | 21.61 |
PBT Margin (%) | 19.02 | 19.25 | 20.85 | 21.54 | 19.89 |
Net Profit Margin (%) | 14.60 | 14.76 | 16.01 | 17.76 | 16.67 |
NP After MI And SOA Margin (%) | 14.85 | 14.80 | 15.97 | 17.73 | 16.63 |
Return on Networth / Equity (%) | 18.67 | 19.02 | 20.75 | 22.09 | 21.87 |
Return on Capital Employeed (%) | 22.18 | 22.88 | 26.71 | 26.38 | 27.24 |
Return On Assets (%) | 12.18 | 12.50 | 14.15 | 15.61 | 15.44 |
Long Term Debt / Equity (X) | 0.05 | 0.03 | 0.02 | 0.01 | 0.02 |
Total Debt / Equity (X) | 0.11 | 0.11 | 0.10 | 0.06 | 0.07 |
Asset Turnover Ratio (%) | 0.86 | 0.80 | 0.84 | 0.85 | 0.86 |
Current Ratio (X) | 1.45 | 1.18 | 1.30 | 1.63 | 1.98 |
Quick Ratio (X) | 0.94 | 0.61 | 0.72 | 1.04 | 1.42 |
Inventory Turnover Ratio (X) | 2.61 | 2.22 | 2.17 | 2.21 | 2.32 |
Dividend Payout Ratio (NP) (%) | 52.41 | 53.96 | 55.90 | 34.96 | 42.75 |
Dividend Payout Ratio (CP) (%) | 43.07 | 45.65 | 48.80 | 30.62 | 37.09 |
Earning Retention Ratio (%) | 47.59 | 46.04 | 44.10 | 65.04 | 57.25 |
Cash Earning Retention Ratio (%) | 56.93 | 54.35 | 51.20 | 69.38 | 62.91 |
Interest Coverage Ratio (X) | 23.21 | 33.35 | 68.57 | 75.56 | 42.34 |
Interest Coverage Ratio (Post Tax) (X) | 15.59 | 22.77 | 48.39 | 56.05 | 32.25 |
Enterprise Value (Cr.) | 93630.67 | 97722.09 | 95194.73 | 94754.25 | 79255.90 |
EV / Net Operating Revenue (X) | 7.55 | 8.48 | 8.74 | 9.93 | 9.13 |
EV / EBITDA (X) | 32.48 | 37.45 | 35.96 | 40.70 | 37.78 |
MarketCap / Net Operating Revenue (X) | 7.47 | 8.38 | 8.71 | 10.01 | 9.16 |
Retention Ratios (%) | 47.58 | 46.03 | 44.09 | 65.03 | 57.24 |
Price / BV (X) | 9.40 | 10.76 | 11.32 | 12.47 | 12.04 |
Price / Net Operating Revenue (X) | 7.47 | 8.38 | 8.71 | 10.01 | 9.16 |
EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Dabur India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 10.40. This value is within the healthy range. It has increased from 9.64 (Mar 23) to 10.40, marking an increase of 0.76.
- For Diluted EPS (Rs.), as of Mar 24, the value is 10.38. This value is within the healthy range. It has increased from 9.61 (Mar 23) to 10.38, marking an increase of 0.77.
- For Cash EPS (Rs.), as of Mar 24, the value is 12.48. This value is within the healthy range. It has increased from 11.37 (Mar 23) to 12.48, marking an increase of 1.11.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 58.14. It has increased from 53.29 (Mar 23) to 58.14, marking an increase of 4.85.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 58.14. It has increased from 53.29 (Mar 23) to 58.14, marking an increase of 4.85.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 70.00. It has increased from 65.07 (Mar 23) to 70.00, marking an increase of 4.93.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 16.27. This value is within the healthy range. It has increased from 14.73 (Mar 23) to 16.27, marking an increase of 1.54.
- For PBIT / Share (Rs.), as of Mar 24, the value is 14.01. This value is within the healthy range. It has increased from 12.97 (Mar 23) to 14.01, marking an increase of 1.04.
- For PBT / Share (Rs.), as of Mar 24, the value is 13.31. This value is within the healthy range. It has increased from 12.53 (Mar 23) to 13.31, marking an increase of 0.78.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 10.22. This value is within the healthy range. It has increased from 9.61 (Mar 23) to 10.22, marking an increase of 0.61.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 10.40. This value is within the healthy range. It has increased from 9.64 (Mar 23) to 10.40, marking an increase of 0.76.
- For PBDIT Margin (%), as of Mar 24, the value is 23.23. This value is within the healthy range. It has increased from 22.63 (Mar 23) to 23.23, marking an increase of 0.60.
- For PBIT Margin (%), as of Mar 24, the value is 20.02. This value exceeds the healthy maximum of 20. It has increased from 19.93 (Mar 23) to 20.02, marking an increase of 0.09.
- For PBT Margin (%), as of Mar 24, the value is 19.02. This value is within the healthy range. It has decreased from 19.25 (Mar 23) to 19.02, marking a decrease of 0.23.
- For Net Profit Margin (%), as of Mar 24, the value is 14.60. This value exceeds the healthy maximum of 10. It has decreased from 14.76 (Mar 23) to 14.60, marking a decrease of 0.16.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 14.85. This value is within the healthy range. It has increased from 14.80 (Mar 23) to 14.85, marking an increase of 0.05.
- For Return on Networth / Equity (%), as of Mar 24, the value is 18.67. This value is within the healthy range. It has decreased from 19.02 (Mar 23) to 18.67, marking a decrease of 0.35.
- For Return on Capital Employeed (%), as of Mar 24, the value is 22.18. This value is within the healthy range. It has decreased from 22.88 (Mar 23) to 22.18, marking a decrease of 0.70.
- For Return On Assets (%), as of Mar 24, the value is 12.18. This value is within the healthy range. It has decreased from 12.50 (Mar 23) to 12.18, marking a decrease of 0.32.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.03 (Mar 23) to 0.05, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.11. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.11.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.86. It has increased from 0.80 (Mar 23) to 0.86, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 24, the value is 1.45. This value is below the healthy minimum of 1.5. It has increased from 1.18 (Mar 23) to 1.45, marking an increase of 0.27.
- For Quick Ratio (X), as of Mar 24, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.61 (Mar 23) to 0.94, marking an increase of 0.33.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.61. This value is below the healthy minimum of 4. It has increased from 2.22 (Mar 23) to 2.61, marking an increase of 0.39.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 52.41. This value exceeds the healthy maximum of 50. It has decreased from 53.96 (Mar 23) to 52.41, marking a decrease of 1.55.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 43.07. This value is within the healthy range. It has decreased from 45.65 (Mar 23) to 43.07, marking a decrease of 2.58.
- For Earning Retention Ratio (%), as of Mar 24, the value is 47.59. This value is within the healthy range. It has increased from 46.04 (Mar 23) to 47.59, marking an increase of 1.55.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 56.93. This value is within the healthy range. It has increased from 54.35 (Mar 23) to 56.93, marking an increase of 2.58.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 23.21. This value is within the healthy range. It has decreased from 33.35 (Mar 23) to 23.21, marking a decrease of 10.14.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 15.59. This value is within the healthy range. It has decreased from 22.77 (Mar 23) to 15.59, marking a decrease of 7.18.
- For Enterprise Value (Cr.), as of Mar 24, the value is 93,630.67. It has decreased from 97,722.09 (Mar 23) to 93,630.67, marking a decrease of 4,091.42.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 7.55. This value exceeds the healthy maximum of 3. It has decreased from 8.48 (Mar 23) to 7.55, marking a decrease of 0.93.
- For EV / EBITDA (X), as of Mar 24, the value is 32.48. This value exceeds the healthy maximum of 15. It has decreased from 37.45 (Mar 23) to 32.48, marking a decrease of 4.97.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 7.47. This value exceeds the healthy maximum of 3. It has decreased from 8.38 (Mar 23) to 7.47, marking a decrease of 0.91.
- For Retention Ratios (%), as of Mar 24, the value is 47.58. This value is within the healthy range. It has increased from 46.03 (Mar 23) to 47.58, marking an increase of 1.55.
- For Price / BV (X), as of Mar 24, the value is 9.40. This value exceeds the healthy maximum of 3. It has decreased from 10.76 (Mar 23) to 9.40, marking a decrease of 1.36.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 7.47. This value exceeds the healthy maximum of 3. It has decreased from 8.38 (Mar 23) to 7.47, marking a decrease of 0.91.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dabur India Ltd:
- Net Profit Margin: 14.6%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.18% (Industry Average ROCE: 36.43%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.67% (Industry Average ROE: 29.37%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 15.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.94
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 49.7 (Industry average Stock P/E: 46.82)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.11
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.6%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Personal Care | 8/3, Asaf Ali Road, New Delhi Delhi 110002 | investors@dabur.com http://www.dabur.com |
Management | |
---|---|
Name | Position Held |
Mr. Mohit Burman | Chairman |
Mr. Saket Burman | Vice Chairman |
Mr. P D Narang | Whole Time Director |
Mr. Mohit Malhotra | WholeTime Director & CEO |
Mr. Aditya Burman | Director |
Mr. Amit Burman | Director |
Mr. Mukesh Butani | Lead Independent Director |
Mr. Ajit Mohan Sharan | Independent Director |
Mrs. Falguni Sanjay Nayar | Independent Director |
Mr. Rajiv Mehrishi | Independent Director |
Mrs. Satyavati Berera | Independent Director |
Mr. P N Vijay | Independent Director |
Mr. R C Bhargava | Independent Director |
Dr. S Narayan | Independent Director |
Dr. Ajay Dua | Independent Director |
Mr. Romesh Sobti | Independent Director |
FAQ
What is the latest intrinsic value of Dabur India Ltd?
The latest intrinsic value of Dabur India Ltd as on 10 March 2025 is ₹451.54, which is 8.96% lower than the current market price of 496.00, indicating the stock is overvalued by 8.96%. The intrinsic value of Dabur India Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹87,872 Cr. and recorded a high/low of ₹672/480 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹10,185 Cr and total liabilities of ₹16,373 Cr.
What is the Market Cap of Dabur India Ltd?
The Market Cap of Dabur India Ltd is 87,872 Cr..
What is the current Stock Price of Dabur India Ltd as on 10 March 2025?
The current stock price of Dabur India Ltd as on 10 March 2025 is ₹496.
What is the High / Low of Dabur India Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Dabur India Ltd stocks is ₹672/480.
What is the Stock P/E of Dabur India Ltd?
The Stock P/E of Dabur India Ltd is 49.7.
What is the Book Value of Dabur India Ltd?
The Book Value of Dabur India Ltd is 58.5.
What is the Dividend Yield of Dabur India Ltd?
The Dividend Yield of Dabur India Ltd is 1.11 %.
What is the ROCE of Dabur India Ltd?
The ROCE of Dabur India Ltd is 22.3 %.
What is the ROE of Dabur India Ltd?
The ROE of Dabur India Ltd is 19.2 %.
What is the Face Value of Dabur India Ltd?
The Face Value of Dabur India Ltd is 1.00.